Brief: Next Science Says To Deliver Increasing Patient Access Across Product Portfolio Through Fy23
28/02/2023 01:38
Feb 28 (Reuters) - Next Science Ltd NXS.AX :
* LOOK FORWARD TO DELIVERING INCREASING PENETRATION AND
PATIENT
ACCESS ACROSS PRODUCT PORTFOLIO THROUGH FY23
* AS WE MOVE INTO FY23, WE EXPECT OUR DIRECT BUSINESS TO
CONTINUE
ITS TRAJECTORY
Source text for Eikon: ID:nASX5L7cPC
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Next Science
See all newsBrief: ASX Says Next Science Limited Will Be Removed From Official List
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets